{"transactions":[{"id":736187,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-16T20:05:16.000Z","date":"2026-06-15","kind":"grant","planned":false,"acquired":true,"shares":31000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1. The shares subject to the Annual Grant will vest in full upon the first anniversary of the date of grant, subject to the Eligible Director's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control."}],"balance_after":31000,"derivative":{"exercise_price":3.94,"exercise_date":"2027-06-15","expiration_date":"2036-06-14","underlying":"Common Stock","underlying_shares":31000},"source":{"system":"sec-edgar","filing":"0001213900-26-069246","document":"marketforms-73183.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000121390026069246/marketforms-73183.xml","form_type":"4"}},{"id":1022218,"issuer":{"id":5561,"kind":"organization","name":"Prelude Therapeutics Inc"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CMO"}}],"security":"Restricted Stock Unit","published_at":"2025-10-07T11:05:37.000Z","date":"2025-10-04","kind":"exercise","planned":false,"acquired":false,"shares":9375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs were granted on May 2, 2022 and vest according to the reporting person's employment agreement. The RSUs vested as to 1/4 of the total shares on April 4, 2023, and 1/16 of the remaining shares shall vest quarterly thereafter until fully vested, subject to the continued service of the Reporting Person to the Issuer through each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs were granted on May 2, 2022 and vest according to the reporting person's employment agreement. The RSUs vested as to 1/4 of the total shares on April 4, 2023, and 1/16 of the remaining shares shall vest quarterly thereafter until fully vested, subject to the continued service of the Reporting Person to the Issuer through each vesting date."}],"balance_after":18750,"derivative":{"underlying":"Common Stock","underlying_shares":9375},"source":{"system":"sec-edgar","filing":"0001683913-25-000004","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000168391325000004/primarydocument.xml","form_type":"4"}},{"id":1022217,"issuer":{"id":5561,"kind":"organization","name":"Prelude Therapeutics Inc"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CMO"}}],"security":"Common Stock","published_at":"2025-10-07T11:05:37.000Z","date":"2025-10-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":3355,"price":1.47,"value":4931.85,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the tax withholding obligation in connection with the vesting of RSUs."}],"balance_after":86917,"source":{"system":"sec-edgar","filing":"0001683913-25-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000168391325000004/primarydocument.xml","form_type":"4"}},{"id":1022216,"issuer":{"id":5561,"kind":"organization","name":"Prelude Therapeutics Inc"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CMO"}}],"security":"Common Stock","published_at":"2025-10-07T11:05:37.000Z","date":"2025-10-04","kind":"exercise","planned":false,"acquired":true,"shares":9375,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer's Common Stock."}],"balance_after":90272,"source":{"system":"sec-edgar","filing":"0001683913-25-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000168391325000004/primarydocument.xml","form_type":"4"}},{"id":1090605,"issuer":{"id":5561,"kind":"organization","name":"Prelude Therapeutics Inc"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CMO"}}],"security":"Restricted Stock Unit","published_at":"2025-07-08T20:06:56.000Z","date":"2025-07-04","kind":"exercise","planned":false,"acquired":false,"shares":9375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs were granted on May 2, 2022 and vest according to the reporting person's employment agreement. The RSUs vested as to 1/4 of the total shares on April 4, 2023, and 1/16 of the remaining shares shall vest quarterly thereafter until fully vested, subject to the continued service of the Reporting Person to the Issuer through each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs were granted on May 2, 2022 and vest according to the reporting person's employment agreement. The RSUs vested as to 1/4 of the total shares on April 4, 2023, and 1/16 of the remaining shares shall vest quarterly thereafter until fully vested, subject to the continued service of the Reporting Person to the Issuer through each vesting date."}],"balance_after":28125,"derivative":{"underlying":"Common Stock","underlying_shares":9375},"source":{"system":"sec-edgar","filing":"0001562180-25-005346","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000156218025005346/primarydocument.xml","form_type":"4"}},{"id":1090604,"issuer":{"id":5561,"kind":"organization","name":"Prelude Therapeutics Inc"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CMO"}}],"security":"Common Stock","published_at":"2025-07-08T20:06:56.000Z","date":"2025-07-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":3355,"price":0.7939,"value":2663.5345,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the tax withholding obligation in connection with the vesting of RSUs."}],"balance_after":80897,"source":{"system":"sec-edgar","filing":"0001562180-25-005346","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000156218025005346/primarydocument.xml","form_type":"4"}},{"id":1090603,"issuer":{"id":5561,"kind":"organization","name":"Prelude Therapeutics Inc"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CMO"}}],"security":"Common Stock","published_at":"2025-07-08T20:06:56.000Z","date":"2025-07-04","kind":"exercise","planned":false,"acquired":true,"shares":9375,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer's Common Stock."}],"balance_after":84252,"source":{"system":"sec-edgar","filing":"0001562180-25-005346","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000156218025005346/primarydocument.xml","form_type":"4"}},{"id":1111666,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T20:05:12.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the Annual Grant will vest in full upon the first anniversary of the date of grant, subject to the Eligible Director's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control."}],"balance_after":24000,"derivative":{"exercise_price":3.26,"exercise_date":"2026-06-12","expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001213900-25-054284","document":"marketforms-69814.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000121390025054284/marketforms-69814.xml","form_type":"4"}},{"id":1176677,"issuer":{"id":5561,"kind":"organization","name":"Prelude Therapeutics Inc"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CMO"}}],"security":"Restricted Stock Unit","published_at":"2025-04-07T20:11:20.000Z","date":"2025-04-04","kind":"exercise","planned":false,"acquired":false,"shares":9375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs were granted on May 2, 2022 and vest according to the reporting person's employment agreement. The RSUs vested as to 1/4 of the total shares on April 4, 2023, and 1/16 of the remaining shares shall vest quarterly thereafter until fully vested, subject to the continued service of the Reporting Person to the Issuer through each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs were granted on May 2, 2022 and vest according to the reporting person's employment agreement. The RSUs vested as to 1/4 of the total shares on April 4, 2023, and 1/16 of the remaining shares shall vest quarterly thereafter until fully vested, subject to the continued service of the Reporting Person to the Issuer through each vesting date."}],"balance_after":37500,"derivative":{"underlying":"Common Stock","underlying_shares":9375},"source":{"system":"sec-edgar","filing":"0001562180-25-003036","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000156218025003036/primarydocument.xml","form_type":"4"}},{"id":1176676,"issuer":{"id":5561,"kind":"organization","name":"Prelude Therapeutics Inc"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CMO"}}],"security":"Common Stock","published_at":"2025-04-07T20:11:20.000Z","date":"2025-04-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":3355,"price":0.675,"value":2264.625,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the tax withholding obligation in connection with the vesting of RSUs."}],"balance_after":74877,"source":{"system":"sec-edgar","filing":"0001562180-25-003036","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000156218025003036/primarydocument.xml","form_type":"4"}},{"id":1176675,"issuer":{"id":5561,"kind":"organization","name":"Prelude Therapeutics Inc"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CMO"}}],"security":"Common Stock","published_at":"2025-04-07T20:11:20.000Z","date":"2025-04-04","kind":"exercise","planned":false,"acquired":true,"shares":9375,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer's Common Stock."}],"balance_after":78232,"source":{"system":"sec-edgar","filing":"0001562180-25-003036","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000156218025003036/primarydocument.xml","form_type":"4"}},{"id":1281859,"issuer":{"id":5561,"kind":"organization","name":"Prelude Therapeutics Inc"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CMO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-02-05T21:31:16.000Z","date":"2025-02-04","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 25% of the total shares on Feb 4, 2026, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":200000,"derivative":{"exercise_price":1.11,"expiration_date":"2035-02-04","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001562180-25-000956","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000156218025000956/primarydocument.xml","form_type":"4"}},{"id":1308076,"issuer":{"id":5561,"kind":"organization","name":"Prelude Therapeutics Inc"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CMO"}}],"security":"Restricted Stock Unit","published_at":"2025-01-07T21:15:22.000Z","date":"2025-01-04","kind":"exercise","planned":false,"acquired":true,"shares":9375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs were granted on May 2, 2022 and vest according to the reporting person's employment agreement. The RSUs vested as to 1/4 of the total shares on April 4, 2023, and 1/16 of the remaining shares shall vest quarterly thereafter until fully vested, subject to the continued service of the Reporting Person to the Issuer through each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs were granted on May 2, 2022 and vest according to the reporting person's employment agreement. The RSUs vested as to 1/4 of the total shares on April 4, 2023, and 1/16 of the remaining shares shall vest quarterly thereafter until fully vested, subject to the continued service of the Reporting Person to the Issuer through each vesting date."}],"balance_after":46875,"derivative":{"underlying":"Common Stock","underlying_shares":9375},"source":{"system":"sec-edgar","filing":"0001562180-25-000237","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000156218025000237/primarydocument.xml","form_type":"4"}},{"id":1308075,"issuer":{"id":5561,"kind":"organization","name":"Prelude Therapeutics Inc"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CMO"}}],"security":"Common Stock","published_at":"2025-01-07T21:15:22.000Z","date":"2025-01-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":3859,"price":1.39,"value":5364.01,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the tax withholding obligation in connection with the vesting of RSUs."}],"balance_after":68857,"source":{"system":"sec-edgar","filing":"0001562180-25-000237","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000156218025000237/primarydocument.xml","form_type":"4"}},{"id":1308074,"issuer":{"id":5561,"kind":"organization","name":"Prelude Therapeutics Inc"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CMO"}}],"security":"Common Stock","published_at":"2025-01-07T21:15:22.000Z","date":"2025-01-04","kind":"exercise","planned":false,"acquired":true,"shares":9375,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer's Common Stock."}],"balance_after":72716,"source":{"system":"sec-edgar","filing":"0001562180-25-000237","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000156218025000237/primarydocument.xml","form_type":"4"}},{"id":1390117,"issuer":{"id":5561,"kind":"organization","name":"Prelude Therapeutics Inc"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CMO"}}],"security":"Restricted Stock Unit","published_at":"2024-10-07T20:10:21.000Z","date":"2024-10-04","kind":"exercise","planned":false,"acquired":false,"shares":9375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs were granted on May 2, 2022 and vest according to the reporting person's employment agreement. The RSUs vested as to 1/4 of the total shares on April 4, 2023, and 1/16 of the remaining shares shall vest quarterly thereafter until fully vested, subject to the continued service of the Reporting Person to the Issuer through each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs were granted on May 2, 2022 and vest according to the reporting person's employment agreement. The RSUs vested as to 1/4 of the total shares on April 4, 2023, and 1/16 of the remaining shares shall vest quarterly thereafter until fully vested, subject to the continued service of the Reporting Person to the Issuer through each vesting date."}],"balance_after":56250,"derivative":{"underlying":"Common Stock","underlying_shares":9375},"source":{"system":"sec-edgar","filing":"0001562180-24-007253","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000156218024007253/primarydocument.xml","form_type":"4"}},{"id":1390116,"issuer":{"id":5561,"kind":"organization","name":"Prelude Therapeutics Inc"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CMO"}}],"security":"Common Stock","published_at":"2024-10-07T20:10:21.000Z","date":"2024-10-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":3349,"price":2,"value":6698.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the tax withholding obligation in connection with the vesting of RSUs."}],"balance_after":63341,"source":{"system":"sec-edgar","filing":"0001562180-24-007253","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000156218024007253/primarydocument.xml","form_type":"4"}},{"id":1390115,"issuer":{"id":5561,"kind":"organization","name":"Prelude Therapeutics Inc"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CMO"}}],"security":"Common Stock","published_at":"2024-10-07T20:10:21.000Z","date":"2024-10-04","kind":"exercise","planned":false,"acquired":true,"shares":9375,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer's Common Stock."}],"balance_after":66690,"source":{"system":"sec-edgar","filing":"0001562180-24-007253","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000156218024007253/primarydocument.xml","form_type":"4"}},{"id":1458331,"issuer":{"id":5561,"kind":"organization","name":"Prelude Therapeutics Inc"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CMO"}}],"security":"Restricted Stock Unit","published_at":"2024-07-08T20:02:16.000Z","date":"2024-07-04","kind":"exercise","planned":false,"acquired":false,"shares":9375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs were granted on May 2, 2022 and vest according to the reporting person's employment agreement. The RSUs vested as to 1/4 of the total shares on April 4, 2023, and 1/16 of the remaining shares shall vest quarterly thereafter until fully vested, subject to the continued service of the Reporting Person to the Issuer through each vesting date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs were granted on May 2, 2022 and vest according to the reporting person's employment agreement. The RSUs vested as to 1/4 of the total shares on April 4, 2023, and 1/16 of the remaining shares shall vest quarterly thereafter until fully vested, subject to the continued service of the Reporting Person to the Issuer through each vesting date"}],"balance_after":65625,"derivative":{"underlying":"Common Stock","underlying_shares":9375},"source":{"system":"sec-edgar","filing":"0001562180-24-005641","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000156218024005641/primarydocument.xml","form_type":"4"}},{"id":1458330,"issuer":{"id":5561,"kind":"organization","name":"Prelude Therapeutics Inc"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CMO"}}],"security":"Common Stock","published_at":"2024-07-08T20:02:16.000Z","date":"2024-07-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":3347,"price":3.6,"value":12049.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the tax withholding obligation in connection with the vesting of RSUs."}],"balance_after":57315,"source":{"system":"sec-edgar","filing":"0001562180-24-005641","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000156218024005641/primarydocument.xml","form_type":"4"}},{"id":1458329,"issuer":{"id":5561,"kind":"organization","name":"Prelude Therapeutics Inc"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CMO"}}],"security":"Common Stock","published_at":"2024-07-08T20:02:16.000Z","date":"2024-07-04","kind":"exercise","planned":false,"acquired":true,"shares":9375,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer's Common Stock."}],"balance_after":60662,"source":{"system":"sec-edgar","filing":"0001562180-24-005641","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000156218024005641/primarydocument.xml","form_type":"4"}},{"id":1484945,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-10T22:00:15.000Z","date":"2024-06-07","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control."}],"balance_after":10000,"derivative":{"exercise_price":2.67,"expiration_date":"2034-06-06","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001213900-24-051377","document":"marketforms-66260.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000121390024051377/marketforms-66260.xml","form_type":"4"}},{"id":1545669,"issuer":{"id":5561,"kind":"organization","name":"Prelude Therapeutics Inc"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CMO"}}],"security":"Restricted Stock Unit","published_at":"2024-04-08T20:11:21.000Z","date":"2024-04-04","kind":"exercise","planned":false,"acquired":false,"shares":9375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs were granted on May 2, 2022 and vest according to the reporting person's employment agreement. The RSUs vested as to 1/4 of the total shares on April 4, 2023, and 1/16 of the remaining shares shall vest quarterly thereafter until fully vested, subject to the continued service of the Reporting Person to the Issuer through each vesting date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs were granted on May 2, 2022 and vest according to the reporting person's employment agreement. The RSUs vested as to 1/4 of the total shares on April 4, 2023, and 1/16 of the remaining shares shall vest quarterly thereafter until fully vested, subject to the continued service of the Reporting Person to the Issuer through each vesting date"}],"balance_after":75000,"derivative":{"underlying":"Common Stock","underlying_shares":9375},"source":{"system":"sec-edgar","filing":"0001562180-24-003347","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000156218024003347/primarydocument.xml","form_type":"4"}},{"id":1545668,"issuer":{"id":5561,"kind":"organization","name":"Prelude Therapeutics Inc"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CMO"}}],"security":"Common Stock","published_at":"2024-04-08T20:11:21.000Z","date":"2024-04-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":3347,"price":4.74,"value":15864.78,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the tax withholding obligation in connection with the vesting of RSUs."}],"balance_after":51287,"source":{"system":"sec-edgar","filing":"0001562180-24-003347","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000156218024003347/primarydocument.xml","form_type":"4"}},{"id":1545667,"issuer":{"id":5561,"kind":"organization","name":"Prelude Therapeutics Inc"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CMO"}}],"security":"Common Stock","published_at":"2024-04-08T20:11:21.000Z","date":"2024-04-04","kind":"exercise","planned":false,"acquired":true,"shares":9375,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer's Common Stock."}],"balance_after":54634,"source":{"system":"sec-edgar","filing":"0001562180-24-003347","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000156218024003347/primarydocument.xml","form_type":"4"}},{"id":1603151,"issuer":{"id":5561,"kind":"organization","name":"Prelude Therapeutics Inc"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CMO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-03-04T23:01:28.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 25% of the total shares on March 1, 2025, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":175000,"derivative":{"exercise_price":4.59,"expiration_date":"2034-02-28","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001562180-24-002130","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000156218024002130/primarydocument.xml","form_type":"4"}},{"id":1684215,"issuer":{"id":5561,"kind":"organization","name":"Prelude Therapeutics Inc"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CMO"}}],"security":"Restricted Stock Unit","published_at":"2024-01-08T22:00:40.000Z","date":"2024-01-04","kind":"exercise","planned":false,"acquired":false,"shares":9375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs were granted on May 2, 2022 and vest according to the reporting person's employment agreement. The RSUs vested as to 1/4 of the total shares on April 4, 2023, and 1/16 of the remaining shares shall vest quarterly thereafter until fully vested, subject to the continued service of the Reporting Person to the Issuer through each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs were granted on May 2, 2022 and vest according to the reporting person's employment agreement. The RSUs vested as to 1/4 of the total shares on April 4, 2023, and 1/16 of the remaining shares shall vest quarterly thereafter until fully vested, subject to the continued service of the Reporting Person to the Issuer through each vesting date."}],"balance_after":84375,"derivative":{"underlying":"Common Stock","underlying_shares":9375},"source":{"system":"sec-edgar","filing":"0001562180-24-000338","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000156218024000338/primarydocument.xml","form_type":"4"}},{"id":1684214,"issuer":{"id":5561,"kind":"organization","name":"Prelude Therapeutics Inc"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CMO"}}],"security":"Common Stock","published_at":"2024-01-08T22:00:40.000Z","date":"2024-01-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":3844,"price":3.77,"value":14491.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the tax withholding obligation in connection with the vesting of RSUs."}],"balance_after":45259,"source":{"system":"sec-edgar","filing":"0001562180-24-000338","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000156218024000338/primarydocument.xml","form_type":"4"}},{"id":1684213,"issuer":{"id":5561,"kind":"organization","name":"Prelude Therapeutics Inc"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CMO"}}],"security":"Common Stock","published_at":"2024-01-08T22:00:40.000Z","date":"2024-01-04","kind":"exercise","planned":false,"acquired":true,"shares":9375,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer's Common Stock."}],"balance_after":49103,"source":{"system":"sec-edgar","filing":"0001562180-24-000338","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000156218024000338/primarydocument.xml","form_type":"4"}},{"id":1763653,"issuer":{"id":5561,"kind":"organization","name":"Prelude Therapeutics Inc"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CMO"}}],"security":"Restricted Stock Unit","published_at":"2023-10-06T13:07:55.000Z","date":"2023-10-04","kind":"exercise","planned":false,"acquired":true,"shares":9375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs were granted on May 2, 2022 and vest according to the reporting person's employment agreement. The RSUs vested as to 1/4 of the total shares on April 4, 2023, and 1/16 of the remaining shares shall vest quarterly thereafter until fully vested, subject to the continued service of the Reporting Person to the Issuer through each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs were granted on May 2, 2022 and vest according to the reporting person's employment agreement. The RSUs vested as to 1/4 of the total shares on April 4, 2023, and 1/16 of the remaining shares shall vest quarterly thereafter until fully vested, subject to the continued service of the Reporting Person to the Issuer through each vesting date."}],"balance_after":93750,"derivative":{"underlying":"Common Stock","underlying_shares":9375},"source":{"system":"sec-edgar","filing":"0001562180-23-007230","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000156218023007230/primarydocument.xml","form_type":"4"}},{"id":1763652,"issuer":{"id":5561,"kind":"organization","name":"Prelude Therapeutics Inc"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CMO"}}],"security":"Common Stock","published_at":"2023-10-06T13:07:55.000Z","date":"2023-10-04","kind":"exercise","planned":false,"acquired":true,"shares":9375,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSU\") represents a contingent right to receive one share of Issuer's Common Stock."}],"balance_after":39728,"source":{"system":"sec-edgar","filing":"0001562180-23-007230","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000156218023007230/primarydocument.xml","form_type":"4"}},{"id":1833903,"issuer":{"id":5561,"kind":"organization","name":"Prelude Therapeutics Inc"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CMO"}}],"security":"Restricted Stock Unit","published_at":"2023-07-06T20:35:26.000Z","date":"2023-07-04","kind":"exercise","planned":false,"acquired":false,"shares":9375,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs were granted on May 2, 2022 and vest according to the reporting person's employment agreement. The RSUs vested as to 1/4 of the total shares on April 4, 2023, and 1/16 of the remaining shares shall vest quarterly thereafter until fully vested, subject to the continued service of the Reporting Person to the Issuer through each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs were granted on May 2, 2022 and vest according to the reporting person's employment agreement. The RSUs vested as to 1/4 of the total shares on April 4, 2023, and 1/16 of the remaining shares shall vest quarterly thereafter until fully vested, subject to the continued service of the Reporting Person to the Issuer through each vesting date."}],"balance_after":103125,"derivative":{"underlying":"Common Stock","underlying_shares":9375},"source":{"system":"sec-edgar","filing":"0001209191-23-041553","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000120919123041553/doc4.xml","form_type":"4"}},{"id":1833902,"issuer":{"id":5561,"kind":"organization","name":"Prelude Therapeutics Inc"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CMO"}}],"security":"Common Stock","published_at":"2023-07-06T20:35:26.000Z","date":"2023-07-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":3242,"price":4.65,"value":15075.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the tax withholding obligation in connection with the vesting of RSUs."}],"balance_after":30353,"source":{"system":"sec-edgar","filing":"0001209191-23-041553","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000120919123041553/doc4.xml","form_type":"4"}},{"id":1833901,"issuer":{"id":5561,"kind":"organization","name":"Prelude Therapeutics Inc"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CMO"}}],"security":"Common Stock","published_at":"2023-07-06T20:35:26.000Z","date":"2023-07-04","kind":"exercise","planned":false,"acquired":true,"shares":9375,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer's Common Stock."}],"balance_after":33595,"source":{"system":"sec-edgar","filing":"0001209191-23-041553","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000120919123041553/doc4.xml","form_type":"4"}},{"id":1862332,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-08T20:10:39.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control."}],"balance_after":10000,"derivative":{"exercise_price":2.85,"expiration_date":"2033-06-06","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001213900-23-047466","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000121390023047466/ownership.xml","form_type":"4"}},{"id":1923793,"issuer":{"id":5561,"kind":"organization","name":"Prelude Therapeutics Inc"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CMO"}}],"security":"Restricted Stock Unit","published_at":"2023-04-06T22:19:08.000Z","date":"2023-04-04","kind":"exercise","planned":false,"acquired":false,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (\"RSUs\") represents a contingent right to receive one share of Issuer's Common Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs were granted on May 2, 2022 and vest according to the reporting person's employment agreement. The RSUs vested as to 1/4 of the total shares on April 4, 2023, and 1/16 of the remaining shares shall vest quarterly thereafter until fully vested, subject to the continued service of the Reporting Person to the Issuer through each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs were granted on May 2, 2022 and vest according to the reporting person's employment agreement. The RSUs vested as to 1/4 of the total shares on April 4, 2023, and 1/16 of the remaining shares shall vest quarterly thereafter until fully vested, subject to the continued service of the Reporting Person to the Issuer through each vesting date."}],"balance_after":112500,"derivative":{"underlying":"Common Stock","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001562180-23-003481","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000156218023003481/primarydocument.xml","form_type":"4"}},{"id":1923792,"issuer":{"id":5561,"kind":"organization","name":"Prelude Therapeutics Inc"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CMO"}}],"security":"Common Stock","published_at":"2023-04-06T22:19:08.000Z","date":"2023-04-06","kind":"sale","planned":false,"acquired":false,"shares":13280,"price":6.12,"value":81273.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the aggregate number of shares sold by the reporting person as a result of a mandatory sale to cover taxes and fees due upon the release and settlement of the RSUs. The reporting person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.90 to $6.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein."}],"balance_after":24220,"source":{"system":"sec-edgar","filing":"0001562180-23-003481","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000156218023003481/primarydocument.xml","form_type":"4"}},{"id":1923791,"issuer":{"id":5561,"kind":"organization","name":"Prelude Therapeutics Inc"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CMO"}}],"security":"Common Stock","published_at":"2023-04-06T22:19:08.000Z","date":"2023-04-04","kind":"exercise","planned":false,"acquired":true,"shares":37500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (\"RSUs\") represents a contingent right to receive one share of Issuer's Common Stock."}],"balance_after":37500,"source":{"system":"sec-edgar","filing":"0001562180-23-003481","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000156218023003481/primarydocument.xml","form_type":"4"}},{"id":2024793,"issuer":{"id":5561,"kind":"organization","name":"Prelude Therapeutics Inc"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CMO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-02-09T21:07:27.000Z","date":"2023-02-07","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 25% of the total shares on February 7, 2024, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":150000,"derivative":{"exercise_price":7.2,"expiration_date":"2033-02-06","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001562180-23-001167","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000156218023001167/primarydocument.xml","form_type":"4"}},{"id":2237774,"issuer":{"id":6203,"kind":"organization","name":"Protara Therapeutics, Inc."},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-09T20:10:22.000Z","date":"2022-06-08","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares will vest in equal monthly installments over the 12 months following the date of grant, provided that the shares will, in any case, be fully vested on the date of the Company's next annual stockholder meeting, subject to the optionholder's continuous service as a member of the Board through such vesting date and will vest in full upon a Change of Control."}],"balance_after":10000,"derivative":{"exercise_price":3.5,"expiration_date":"2032-06-07","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001213900-22-031996","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000121390022031996/ownership.xml","form_type":"4"}},{"id":2282330,"issuer":{"id":5561,"kind":"organization","name":"Prelude Therapeutics Inc"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CMO"}}],"security":"Restricted Stock Unit","published_at":"2022-05-04T21:46:02.000Z","date":"2022-05-02","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs shall vest as to 1/4 of the total shares on April 4, 2023, and 1/16 of the remaining shares shall vest quarterly thereafter until fully vested, subject to the continued service of the Reporting Person to the Issuer through each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs shall vest as to 1/4 of the total shares on April 4, 2023, and 1/16 of the remaining shares shall vest quarterly thereafter until fully vested, subject to the continued service of the Reporting Person to the Issuer through each vesting date."}],"balance_after":150000,"derivative":{"underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-22-027196","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000120919122027196/doc4.xml","form_type":"4"}},{"id":2282329,"issuer":{"id":5561,"kind":"organization","name":"Prelude Therapeutics Inc"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President, CMO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-05-04T21:46:02.000Z","date":"2022-05-02","kind":"grant","acquired":true,"shares":460000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 25% of the total shares on April 4, 2023, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":460000,"derivative":{"exercise_price":4.86,"expiration_date":"2032-04-30","underlying":"Common Stock","underlying_shares":460000},"source":{"system":"sec-edgar","filing":"0001209191-22-027196","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000120919122027196/doc4.xml","form_type":"4"}},{"id":2469911,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Hematology"}}],"security":"Share Option (Right to Buy)","published_at":"2021-12-16T22:50:15.000Z","date":"2021-12-14","kind":"exercise","acquired":false,"shares":19500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"The number of securities underlying the option and the exercise price therefor are represented in ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"These securities vest over a four-year period as follows: 25% on June 5, 2020, and the remaining in 36 successive equal monthly installments, subject to continued service. Unvested shares are subject to accelerated vesting upon certain termination events following a change in control."}],"balance_after":211276,"derivative":{"exercise_price":9.23,"expiration_date":"2029-06-04","underlying":"Ordinary Shares","underlying_shares":19500},"source":{"system":"sec-edgar","filing":"0001651308-21-000255","document":"wf-form4_163969500095782.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000165130821000255/wf-form4_163969500095782.xml","form_type":"4"}},{"id":2469910,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Hematology"}}],"security":"American Depositary Shares","published_at":"2021-12-16T22:50:15.000Z","date":"2021-12-14","kind":"sale","acquired":false,"shares":100,"price":284.52,"value":28452.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 17, 2018, as most recently amended on December 15, 2020."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001651308-21-000255","document":"wf-form4_163969500095782.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000165130821000255/wf-form4_163969500095782.xml","form_type":"4"}},{"id":2469909,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Hematology"}}],"security":"American Depositary Shares","published_at":"2021-12-16T22:50:15.000Z","date":"2021-12-14","kind":"sale","acquired":false,"shares":200,"price":281.635,"value":56327.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 17, 2018, as most recently amended on December 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $281.49 to $281.78, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":100,"source":{"system":"sec-edgar","filing":"0001651308-21-000255","document":"wf-form4_163969500095782.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000165130821000255/wf-form4_163969500095782.xml","form_type":"4"}},{"id":2469908,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Hematology"}}],"security":"American Depositary Shares","published_at":"2021-12-16T22:50:15.000Z","date":"2021-12-14","kind":"sale","acquired":false,"shares":100,"price":278.79,"value":27879.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 17, 2018, as most recently amended on December 15, 2020."}],"balance_after":300,"source":{"system":"sec-edgar","filing":"0001651308-21-000255","document":"wf-form4_163969500095782.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000165130821000255/wf-form4_163969500095782.xml","form_type":"4"}},{"id":2469907,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Hematology"}}],"security":"American Depositary Shares","published_at":"2021-12-16T22:50:15.000Z","date":"2021-12-14","kind":"sale","acquired":false,"shares":500,"price":278.212,"value":139106.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 17, 2018, as most recently amended on December 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $277.78 to $278.67, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":400,"source":{"system":"sec-edgar","filing":"0001651308-21-000255","document":"wf-form4_163969500095782.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000165130821000255/wf-form4_163969500095782.xml","form_type":"4"}},{"id":2469906,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Hematology"}}],"security":"American Depositary Shares","published_at":"2021-12-16T22:50:15.000Z","date":"2021-12-14","kind":"sale","acquired":false,"shares":300,"price":276.9533,"value":83085.99,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 17, 2018, as most recently amended on December 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $276.57 to $277.37, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":900,"source":{"system":"sec-edgar","filing":"0001651308-21-000255","document":"wf-form4_163969500095782.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000165130821000255/wf-form4_163969500095782.xml","form_type":"4"}},{"id":2469905,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Hematology"}}],"security":"American Depositary Shares","published_at":"2021-12-16T22:50:15.000Z","date":"2021-12-14","kind":"sale","acquired":false,"shares":300,"price":274.5367,"value":82361.01,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 17, 2018, as most recently amended on December 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $274.27 to $274.70, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":1200,"source":{"system":"sec-edgar","filing":"0001651308-21-000255","document":"wf-form4_163969500095782.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000165130821000255/wf-form4_163969500095782.xml","form_type":"4"}},{"id":2469904,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Hematology"}}],"security":"American Depositary Shares","published_at":"2021-12-16T22:50:15.000Z","date":"2021-12-14","kind":"exercise","acquired":true,"shares":1500,"price":119.96,"value":179940.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."}],"balance_after":1500,"source":{"system":"sec-edgar","filing":"0001651308-21-000255","document":"wf-form4_163969500095782.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000165130821000255/wf-form4_163969500095782.xml","form_type":"4"}},{"id":2488779,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Hematology"}}],"security":"American Depositary Shares","published_at":"2021-12-02T23:21:34.000Z","date":"2021-12-01","kind":"sale","acquired":false,"shares":519,"price":362.45,"value":188111.55,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a performance-based restricted share unit award previously granted to the Reporting Person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001651308-21-000237","document":"wf-form4_163848727472638.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000165130821000237/wf-form4_163848727472638.xml","form_type":"4"}},{"id":2488778,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Hematology"}}],"security":"American Depositary Shares","published_at":"2021-12-02T23:21:34.000Z","date":"2021-12-01","kind":"sale","acquired":false,"shares":530,"price":357.3229,"value":189381.137,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a performance-based restricted share unit award previously granted to the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $357.158 to $357.595, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":519,"source":{"system":"sec-edgar","filing":"0001651308-21-000237","document":"wf-form4_163848727472638.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000165130821000237/wf-form4_163848727472638.xml","form_type":"4"}},{"id":2488777,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Hematology"}}],"security":"American Depositary Shares","published_at":"2021-12-02T23:21:34.000Z","date":"2021-11-30","kind":"grant","acquired":true,"shares":1049,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"shares","element":"transactionShares","label":"F1","text":"Vesting of a portion of a performance-based restricted share unit award upon satisfaction of performance conditions."}],"balance_after":1049,"source":{"system":"sec-edgar","filing":"0001651308-21-000237","document":"wf-form4_163848727472638.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000165130821000237/wf-form4_163848727472638.xml","form_type":"4"}},{"id":2488776,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Hematology"}}],"security":"Ordinary Shares","published_at":"2021-12-02T23:21:34.000Z","date":"2021-11-30","kind":"grant","acquired":true,"shares":14820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Vesting of a portion of a performance-based restricted share unit award upon satisfaction of performance conditions."}],"balance_after":160055,"source":{"system":"sec-edgar","filing":"0001651308-21-000237","document":"wf-form4_163848727472638.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000165130821000237/wf-form4_163848727472638.xml","form_type":"4"}},{"id":2502931,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Hematology"}}],"security":"Share Option (Right to Buy)","published_at":"2021-11-19T23:18:42.000Z","date":"2021-11-17","kind":"exercise","acquired":false,"shares":19500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"The number of securities underlying the option and the exercise price therefor are represented in ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"These securities vest over a four-year period as follows: 25% on June 5, 2020, and the remaining in 36 successive equal monthly installments, subject to continued service. Unvested shares are subject to accelerated vesting upon certain termination events following a change in control."}],"balance_after":230776,"derivative":{"exercise_price":9.23,"expiration_date":"2029-06-04","underlying":"Ordinary Shares","underlying_shares":19500},"source":{"system":"sec-edgar","filing":"0001651308-21-000230","document":"wf-form4_163736390377799.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000165130821000230/wf-form4_163736390377799.xml","form_type":"4"}},{"id":2502930,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Hematology"}}],"security":"American Depositary Shares","published_at":"2021-11-19T23:18:42.000Z","date":"2021-11-17","kind":"sale","acquired":false,"shares":300,"price":387.94,"value":116382.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 17, 2018, as most recently amended on December 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $387.82 to $388.00, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001651308-21-000230","document":"wf-form4_163736390377799.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000165130821000230/wf-form4_163736390377799.xml","form_type":"4"}},{"id":2502929,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Hematology"}}],"security":"American Depositary Shares","published_at":"2021-11-19T23:18:42.000Z","date":"2021-11-17","kind":"sale","acquired":false,"shares":100,"price":385.28,"value":38528.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 17, 2018, as most recently amended on December 15, 2020."}],"balance_after":300,"source":{"system":"sec-edgar","filing":"0001651308-21-000230","document":"wf-form4_163736390377799.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000165130821000230/wf-form4_163736390377799.xml","form_type":"4"}},{"id":2502928,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Hematology"}}],"security":"American Depositary Shares","published_at":"2021-11-19T23:18:42.000Z","date":"2021-11-17","kind":"sale","acquired":false,"shares":100,"price":384.16,"value":38416.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 17, 2018, as most recently amended on December 15, 2020."}],"balance_after":400,"source":{"system":"sec-edgar","filing":"0001651308-21-000230","document":"wf-form4_163736390377799.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000165130821000230/wf-form4_163736390377799.xml","form_type":"4"}},{"id":2502927,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Hematology"}}],"security":"American Depositary Shares","published_at":"2021-11-19T23:18:42.000Z","date":"2021-11-17","kind":"sale","acquired":false,"shares":100,"price":382.42,"value":38242.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 17, 2018, as most recently amended on December 15, 2020."}],"balance_after":500,"source":{"system":"sec-edgar","filing":"0001651308-21-000230","document":"wf-form4_163736390377799.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000165130821000230/wf-form4_163736390377799.xml","form_type":"4"}},{"id":2502926,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Hematology"}}],"security":"American Depositary Shares","published_at":"2021-11-19T23:18:42.000Z","date":"2021-11-17","kind":"sale","acquired":false,"shares":200,"price":381.41,"value":76282.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 17, 2018, as most recently amended on December 15, 2020."}],"balance_after":600,"source":{"system":"sec-edgar","filing":"0001651308-21-000230","document":"wf-form4_163736390377799.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000165130821000230/wf-form4_163736390377799.xml","form_type":"4"}},{"id":2502925,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Hematology"}}],"security":"American Depositary Shares","published_at":"2021-11-19T23:18:42.000Z","date":"2021-11-17","kind":"sale","acquired":false,"shares":100,"price":379.8839,"value":37988.39,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 17, 2018, as most recently amended on December 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $379.61 to $380.44, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":800,"source":{"system":"sec-edgar","filing":"0001651308-21-000230","document":"wf-form4_163736390377799.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000165130821000230/wf-form4_163736390377799.xml","form_type":"4"}},{"id":2502924,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Hematology"}}],"security":"American Depositary Shares","published_at":"2021-11-19T23:18:42.000Z","date":"2021-11-17","kind":"sale","acquired":false,"shares":100,"price":377.92,"value":37792.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 17, 2018, as most recently amended on December 15, 2020."}],"balance_after":900,"source":{"system":"sec-edgar","filing":"0001651308-21-000230","document":"wf-form4_163736390377799.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000165130821000230/wf-form4_163736390377799.xml","form_type":"4"}},{"id":2502923,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Hematology"}}],"security":"American Depositary Shares","published_at":"2021-11-19T23:18:42.000Z","date":"2021-11-17","kind":"sale","acquired":false,"shares":300,"price":377.14,"value":113142.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 17, 2018, as most recently amended on December 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $376.89 to $377.37, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":1000,"source":{"system":"sec-edgar","filing":"0001651308-21-000230","document":"wf-form4_163736390377799.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000165130821000230/wf-form4_163736390377799.xml","form_type":"4"}},{"id":2502922,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Hematology"}}],"security":"American Depositary Shares","published_at":"2021-11-19T23:18:42.000Z","date":"2021-11-17","kind":"sale","acquired":false,"shares":200,"price":376.155,"value":75231.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 17, 2018, as most recently amended on December 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $375.76 to $376.55, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":1300,"source":{"system":"sec-edgar","filing":"0001651308-21-000230","document":"wf-form4_163736390377799.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000165130821000230/wf-form4_163736390377799.xml","form_type":"4"}},{"id":2502921,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Hematology"}}],"security":"American Depositary Shares","published_at":"2021-11-19T23:18:42.000Z","date":"2021-11-17","kind":"exercise","acquired":true,"shares":1500,"price":119.96,"value":179940.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."}],"balance_after":1500,"source":{"system":"sec-edgar","filing":"0001651308-21-000230","document":"wf-form4_163736390377799.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000165130821000230/wf-form4_163736390377799.xml","form_type":"4"}},{"id":2537352,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Hematology"}}],"security":"Share Option (Right to Buy)","published_at":"2021-10-21T21:37:32.000Z","date":"2021-10-19","kind":"exercise","acquired":false,"shares":19500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F7","text":"The number of securities underlying the option and the exercise price therefor are represented in ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"These securities vest over a four-year period as follows: 25% on June 5, 2020, and the remaining in 36 successive equal monthly installments, subject to continued service. Unvested shares are subject to accelerated vesting upon certain termination events following a change in control."}],"balance_after":250276,"derivative":{"exercise_price":9.23,"expiration_date":"2029-06-04","underlying":"Ordinary Shares","underlying_shares":19500},"source":{"system":"sec-edgar","filing":"0001651308-21-000209","document":"wf-form4_163485223713937.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000165130821000209/wf-form4_163485223713937.xml","form_type":"4"}},{"id":2537351,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Hematology"}}],"security":"American Depositary Shares","published_at":"2021-10-21T21:37:32.000Z","date":"2021-10-19","kind":"sale","acquired":false,"shares":100,"price":377.71,"value":37771.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2020."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001651308-21-000209","document":"wf-form4_163485223713937.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000165130821000209/wf-form4_163485223713937.xml","form_type":"4"}},{"id":2537350,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Hematology"}}],"security":"American Depositary Shares","published_at":"2021-10-21T21:37:32.000Z","date":"2021-10-19","kind":"sale","acquired":false,"shares":200,"price":376.36,"value":75272.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $375.89 to $376.83, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":100,"source":{"system":"sec-edgar","filing":"0001651308-21-000209","document":"wf-form4_163485223713937.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000165130821000209/wf-form4_163485223713937.xml","form_type":"4"}},{"id":2537349,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Hematology"}}],"security":"American Depositary Shares","published_at":"2021-10-21T21:37:32.000Z","date":"2021-10-19","kind":"sale","acquired":false,"shares":400,"price":375.08,"value":150032.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $374.82 to $375.40, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":300,"source":{"system":"sec-edgar","filing":"0001651308-21-000209","document":"wf-form4_163485223713937.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000165130821000209/wf-form4_163485223713937.xml","form_type":"4"}},{"id":2537348,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Hematology"}}],"security":"American Depositary Shares","published_at":"2021-10-21T21:37:32.000Z","date":"2021-10-19","kind":"sale","acquired":false,"shares":400,"price":373.75,"value":149500.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $373.11 to $374.00, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":700,"source":{"system":"sec-edgar","filing":"0001651308-21-000209","document":"wf-form4_163485223713937.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000165130821000209/wf-form4_163485223713937.xml","form_type":"4"}},{"id":2537347,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Hematology"}}],"security":"American Depositary Shares","published_at":"2021-10-21T21:37:32.000Z","date":"2021-10-19","kind":"sale","acquired":false,"shares":100,"price":371.65,"value":37165.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2020."}],"balance_after":1100,"source":{"system":"sec-edgar","filing":"0001651308-21-000209","document":"wf-form4_163485223713937.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000165130821000209/wf-form4_163485223713937.xml","form_type":"4"}},{"id":2537346,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Hematology"}}],"security":"American Depositary Shares","published_at":"2021-10-21T21:37:32.000Z","date":"2021-10-19","kind":"sale","acquired":false,"shares":100,"price":370.14,"value":37014.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2020."}],"balance_after":1200,"source":{"system":"sec-edgar","filing":"0001651308-21-000209","document":"wf-form4_163485223713937.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000165130821000209/wf-form4_163485223713937.xml","form_type":"4"}},{"id":2537345,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Hematology"}}],"security":"American Depositary Shares","published_at":"2021-10-21T21:37:32.000Z","date":"2021-10-19","kind":"sale","acquired":false,"shares":200,"price":362.045,"value":72409.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $361.94 to $362.15, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":1300,"source":{"system":"sec-edgar","filing":"0001651308-21-000209","document":"wf-form4_163485223713937.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000165130821000209/wf-form4_163485223713937.xml","form_type":"4"}},{"id":2537344,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Hematology"}}],"security":"American Depositary Shares","published_at":"2021-10-21T21:37:32.000Z","date":"2021-10-19","kind":"exercise","acquired":true,"shares":1500,"price":119.96,"value":179940.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."}],"balance_after":1500,"source":{"system":"sec-edgar","filing":"0001651308-21-000209","document":"wf-form4_163485223713937.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000165130821000209/wf-form4_163485223713937.xml","form_type":"4"}},{"id":2562019,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Hematology"}}],"security":"Share Option (Right to Buy)","published_at":"2021-09-22T22:15:22.000Z","date":"2021-09-20","kind":"exercise","acquired":false,"shares":78000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F15","text":"The number of securities underlying the option and the exercise price therefor are represented in ordinary shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F16","text":"These securities vest over a four-year period as follows: 25% on June 5, 2020, and the remaining in 36 successive equal monthly installments, subject to continued service. Unvested shares are subject to accelerated vesting upon certain termination events following a change in control."}],"balance_after":269776,"derivative":{"exercise_price":9.23,"expiration_date":"2029-06-04","underlying":"Ordinary Shares","underlying_shares":78000},"source":{"system":"sec-edgar","filing":"0001651308-21-000196","document":"wf-form4_163234890624036.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000165130821000196/wf-form4_163234890624036.xml","form_type":"4"}},{"id":2562018,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Hematology"}}],"security":"American Depositary Shares","published_at":"2021-09-22T22:15:22.000Z","date":"2021-09-20","kind":"sale","acquired":false,"shares":100,"price":411.17,"value":41117.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2020."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001651308-21-000196","document":"wf-form4_163234890624036.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000165130821000196/wf-form4_163234890624036.xml","form_type":"4"}},{"id":2562017,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Hematology"}}],"security":"American Depositary Shares","published_at":"2021-09-22T22:15:22.000Z","date":"2021-09-20","kind":"sale","acquired":false,"shares":100,"price":408.69,"value":40869.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2020."}],"balance_after":100,"source":{"system":"sec-edgar","filing":"0001651308-21-000196","document":"wf-form4_163234890624036.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000165130821000196/wf-form4_163234890624036.xml","form_type":"4"}},{"id":2562016,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Hematology"}}],"security":"American Depositary Shares","published_at":"2021-09-22T22:15:22.000Z","date":"2021-09-20","kind":"sale","acquired":false,"shares":150,"price":407.9833,"value":61197.495,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F14","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $407.65 to $408.15, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":200,"source":{"system":"sec-edgar","filing":"0001651308-21-000196","document":"wf-form4_163234890624036.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000165130821000196/wf-form4_163234890624036.xml","form_type":"4"}},{"id":2562015,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Hematology"}}],"security":"American Depositary Shares","published_at":"2021-09-22T22:15:22.000Z","date":"2021-09-20","kind":"sale","acquired":false,"shares":200,"price":406.86,"value":81372.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $406.49 to $407.23, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":350,"source":{"system":"sec-edgar","filing":"0001651308-21-000196","document":"wf-form4_163234890624036.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000165130821000196/wf-form4_163234890624036.xml","form_type":"4"}},{"id":2562014,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Hematology"}}],"security":"American Depositary Shares","published_at":"2021-09-22T22:15:22.000Z","date":"2021-09-20","kind":"sale","acquired":false,"shares":583,"price":401.8586,"value":234283.5638,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $401.35 to $402.26, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":550,"source":{"system":"sec-edgar","filing":"0001651308-21-000196","document":"wf-form4_163234890624036.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000165130821000196/wf-form4_163234890624036.xml","form_type":"4"}},{"id":2562013,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Hematology"}}],"security":"American Depositary Shares","published_at":"2021-09-22T22:15:22.000Z","date":"2021-09-20","kind":"sale","acquired":false,"shares":400,"price":400.5825,"value":160233.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $400.15 to $401.02, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":1133,"source":{"system":"sec-edgar","filing":"0001651308-21-000196","document":"wf-form4_163234890624036.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000165130821000196/wf-form4_163234890624036.xml","form_type":"4"}},{"id":2562012,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Hematology"}}],"security":"American Depositary Shares","published_at":"2021-09-22T22:15:22.000Z","date":"2021-09-20","kind":"sale","acquired":false,"shares":400,"price":398.9975,"value":159599.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F10","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $398.86 to $399.14, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":1533,"source":{"system":"sec-edgar","filing":"0001651308-21-000196","document":"wf-form4_163234890624036.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000165130821000196/wf-form4_163234890624036.xml","form_type":"4"}},{"id":2562011,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Hematology"}}],"security":"American Depositary Shares","published_at":"2021-09-22T22:15:22.000Z","date":"2021-09-20","kind":"sale","acquired":false,"shares":790,"price":398.3661,"value":314709.219,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $397.84 to $398.83, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":1933,"source":{"system":"sec-edgar","filing":"0001651308-21-000196","document":"wf-form4_163234890624036.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000165130821000196/wf-form4_163234890624036.xml","form_type":"4"}},{"id":2562010,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Hematology"}}],"security":"American Depositary Shares","published_at":"2021-09-22T22:15:22.000Z","date":"2021-09-20","kind":"sale","acquired":false,"shares":700,"price":397.1486,"value":278004.02,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $396.73 to $397.67, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":2723,"source":{"system":"sec-edgar","filing":"0001651308-21-000196","document":"wf-form4_163234890624036.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000165130821000196/wf-form4_163234890624036.xml","form_type":"4"}},{"id":2562009,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Hematology"}}],"security":"American Depositary Shares","published_at":"2021-09-22T22:15:22.000Z","date":"2021-09-20","kind":"sale","acquired":false,"shares":700,"price":396,"value":277200.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $395.58 to $396.43, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":3423,"source":{"system":"sec-edgar","filing":"0001651308-21-000196","document":"wf-form4_163234890624036.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000165130821000196/wf-form4_163234890624036.xml","form_type":"4"}},{"id":2562008,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Hematology"}}],"security":"American Depositary Shares","published_at":"2021-09-22T22:15:22.000Z","date":"2021-09-20","kind":"sale","acquired":false,"shares":913,"price":395.1323,"value":360755.7899,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $394.58 to $395.56, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":4123,"source":{"system":"sec-edgar","filing":"0001651308-21-000196","document":"wf-form4_163234890624036.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000165130821000196/wf-form4_163234890624036.xml","form_type":"4"}},{"id":2562007,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Hematology"}}],"security":"American Depositary Shares","published_at":"2021-09-22T22:15:22.000Z","date":"2021-09-20","kind":"sale","acquired":false,"shares":328,"price":393.3409,"value":129015.8152,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $393.22 to $394.10, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":5036,"source":{"system":"sec-edgar","filing":"0001651308-21-000196","document":"wf-form4_163234890624036.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000165130821000196/wf-form4_163234890624036.xml","form_type":"4"}},{"id":2562006,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Hematology"}}],"security":"American Depositary Shares","published_at":"2021-09-22T22:15:22.000Z","date":"2021-09-20","kind":"sale","acquired":false,"shares":536,"price":392.402,"value":210327.472,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $392.11 to $392.66, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":5364,"source":{"system":"sec-edgar","filing":"0001651308-21-000196","document":"wf-form4_163234890624036.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000165130821000196/wf-form4_163234890624036.xml","form_type":"4"}},{"id":2562005,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Hematology"}}],"security":"American Depositary Shares","published_at":"2021-09-22T22:15:22.000Z","date":"2021-09-20","kind":"sale","acquired":false,"shares":100,"price":390.906,"value":39090.6,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 15, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $390.89 to $391.05, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":5900,"source":{"system":"sec-edgar","filing":"0001651308-21-000196","document":"wf-form4_163234890624036.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000165130821000196/wf-form4_163234890624036.xml","form_type":"4"}},{"id":2562004,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Hematology"}}],"security":"American Depositary Shares","published_at":"2021-09-22T22:15:22.000Z","date":"2021-09-20","kind":"exercise","acquired":true,"shares":6000,"price":119.96,"value":719760.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."}],"balance_after":6000,"source":{"system":"sec-edgar","filing":"0001651308-21-000196","document":"wf-form4_163234890624036.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000165130821000196/wf-form4_163234890624036.xml","form_type":"4"}},{"id":2569376,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Hematology"}}],"security":"American Depositary Shares","published_at":"2021-09-15T22:16:00.000Z","date":"2021-09-13","kind":"sale","acquired":false,"shares":1,"price":363.45,"value":363.45,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2021."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001651308-21-000192","document":"wf-form4_163174413509848.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000165130821000192/wf-form4_163174413509848.xml","form_type":"4"}},{"id":2569375,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Hematology"}}],"security":"American Depositary Shares","published_at":"2021-09-15T22:16:00.000Z","date":"2021-09-13","kind":"sale","acquired":false,"shares":1581,"price":362.7977,"value":573583.1637,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $362.35 to $363.29, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":1,"source":{"system":"sec-edgar","filing":"0001651308-21-000192","document":"wf-form4_163174413509848.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000165130821000192/wf-form4_163174413509848.xml","form_type":"4"}},{"id":2569374,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Hematology"}}],"security":"American Depositary Shares","published_at":"2021-09-15T22:16:00.000Z","date":"2021-09-13","kind":"sale","acquired":false,"shares":900,"price":361.05,"value":324945.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $360.65 to $361.61, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":1582,"source":{"system":"sec-edgar","filing":"0001651308-21-000192","document":"wf-form4_163174413509848.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000165130821000192/wf-form4_163174413509848.xml","form_type":"4"}},{"id":2569373,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Hematology"}}],"security":"American Depositary Shares","published_at":"2021-09-15T22:16:00.000Z","date":"2021-09-13","kind":"sale","acquired":false,"shares":1800,"price":359.8828,"value":647789.04,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $359.625 to $360.265, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":2482,"source":{"system":"sec-edgar","filing":"0001651308-21-000192","document":"wf-form4_163174413509848.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000165130821000192/wf-form4_163174413509848.xml","form_type":"4"}},{"id":2569372,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Hematology"}}],"security":"American Depositary Shares","published_at":"2021-09-15T22:16:00.000Z","date":"2021-09-13","kind":"sale","acquired":false,"shares":1700,"price":359.1485,"value":610552.45,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $358.61 to $359.55, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":4282,"source":{"system":"sec-edgar","filing":"0001651308-21-000192","document":"wf-form4_163174413509848.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000165130821000192/wf-form4_163174413509848.xml","form_type":"4"}},{"id":2569371,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Hematology"}}],"security":"American Depositary Shares","published_at":"2021-09-15T22:16:00.000Z","date":"2021-09-13","kind":"sale","acquired":false,"shares":1300,"price":357.5446,"value":464807.98,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $357.15 to $358.125, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":5982,"source":{"system":"sec-edgar","filing":"0001651308-21-000192","document":"wf-form4_163174413509848.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000165130821000192/wf-form4_163174413509848.xml","form_type":"4"}},{"id":2569370,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Hematology"}}],"security":"American Depositary Shares","published_at":"2021-09-15T22:16:00.000Z","date":"2021-09-13","kind":"sale","acquired":false,"shares":1400,"price":356.4571,"value":499039.94,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $356.14 to $356.895, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":7282,"source":{"system":"sec-edgar","filing":"0001651308-21-000192","document":"wf-form4_163174413509848.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000165130821000192/wf-form4_163174413509848.xml","form_type":"4"}},{"id":2569369,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Hematology"}}],"security":"American Depositary Shares","published_at":"2021-09-15T22:16:00.000Z","date":"2021-09-13","kind":"sale","acquired":false,"shares":4219,"price":355.3706,"value":1499308.5614,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 14, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $355.00 to $355.95, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price."}],"balance_after":8682,"source":{"system":"sec-edgar","filing":"0001651308-21-000192","document":"wf-form4_163174413509848.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000165130821000192/wf-form4_163174413509848.xml","form_type":"4"}},{"id":2581683,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Hematology"}}],"security":"American Depositary Shares","published_at":"2021-09-03T00:39:22.000Z","date":"2021-09-02","kind":"sale","acquired":false,"shares":545,"price":327.181,"value":178313.645,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a performance-based restricted share unit award previously granted to the Reporting Person."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001651308-21-000188","document":"wf-form4_163062954715699.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000165130821000188/wf-form4_163062954715699.xml","form_type":"4"}},{"id":2581682,"issuer":{"id":2168,"kind":"organization","name":"BeOne Medicines Ltd.","symbol":"ONC"},"owners":[{"id":37689,"kind":"person","name":"Huang Jane","position":1,"cik":"0001683913","reported_name":"Huang Jane","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CMO, Hematology"}}],"security":"American Depositary Shares","published_at":"2021-09-03T00:39:22.000Z","date":"2021-09-01","kind":"grant","acquired":true,"shares":545,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Each American Depositary Share represents 13 Ordinary Shares."},{"field":"shares","element":"transactionShares","label":"F1","text":"Vesting of a portion of a performance-based restricted share unit award upon satisfaction of performance conditions."}],"balance_after":545,"source":{"system":"sec-edgar","filing":"0001651308-21-000188","document":"wf-form4_163062954715699.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1683913/000165130821000188/wf-form4_163062954715699.xml","form_type":"4"}}],"next_cursor":"2021-09-03T00:39:22.000000Z,2581682"}